학술논문

발행년
-
(예 : 2010-2015)
'학술논문' 에서 검색결과 156건 | 목록 1~10
Academic Journal
Fernández-Miranda I; Department of Medical Oncology, Lymphoma Research Group, Hospital Universitario Puerta de Hierro-Majadahonda, IDIPHISA, Madrid, Spain.; Pedrosa L; Department of Medical Oncology, Lymphoma Research Group, Hospital Universitario Puerta de Hierro-Majadahonda, IDIPHISA, Madrid, Spain.; González-Rincón J; Department of Medical Oncology, Lymphoma Research Group, Hospital Universitario Puerta de Hierro-Majadahonda, IDIPHISA, Madrid, Spain; CoE Data Intelligence, Fujitsu Technology Solutions S.A., Pozuelo de Alarcón, Madrid, Spain.; Espinet B; Translational Research on Hematological Neoplasms Group, Cancer Research Program, Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), Barcelona, Spain; Department of Pathology, Hospital del Mar, Barcelona, Spain.; de la Cruz Vicente F; Department of Hematology, Hospital Universitario Virgen del Rocío, Instituto de Biomedicina de Sevilla (IBIS)/CSIC/Universidad de Sevilla, Seville, Spain.; Climent F; Department of Pathology, Hospital Universitari de Bellvitge-IDIBELL, Barcelona, Spain.; Gómez S; Department of Medical Oncology, Lymphoma Research Group, Hospital Universitario Puerta de Hierro-Majadahonda, IDIPHISA, Madrid, Spain.; Royuela A; Biostatistics Unit, Hospital Universitario Puerta de Hierro-Majadahonda, IDIPHISA. CIBERESP, ISCIII. Madrid, Spain.; Camacho FI; Department of Pathology, Hospital Universitario de Getafe, Madrid, Spain.; Martín-Acosta P; Department of Pathology, Cancer Molecular Pathology Group, Hospital Universitario Puerta de Hierro-Majadahonda, IDIPHISA, Madrid, Spain.; Yanguas-Casás N; Department of Medical Oncology, Lymphoma Research Group, Hospital Universitario Puerta de Hierro-Majadahonda, IDIPHISA, Madrid, Spain; Centro de Investigación Biomédica en Red Fragilidad y Envejecimiento Saludable (CIBERFES), Madrid, Spain.; Domínguez M; Department of Medical Oncology, Lymphoma Research Group, Hospital Universitario Puerta de Hierro-Majadahonda, IDIPHISA, Madrid, Spain.; Méndez M; Department of Medical Oncology, Lymphoma Research Group, Hospital Universitario Puerta de Hierro-Majadahonda, IDIPHISA, Madrid, Spain; Department of Medical Oncology, Hospital Universitario Puerta de Hierro-Majadahonda, IDIPHISA, Madrid, Spain.; Colomo L; Translational Research on Hematological Neoplasms Group, Cancer Research Program, Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), Barcelona, Spain.; Salar A; Department of Hematology, Hospital del Mar, Barcelona, Spain.; Horcajo B; Department of Medical Oncology, Lymphoma Research Group, Hospital Universitario Puerta de Hierro-Majadahonda, IDIPHISA, Madrid, Spain.; Navarro M; Department of Medical Oncology, Lymphoma Research Group, Hospital Universitario Puerta de Hierro-Majadahonda, IDIPHISA, Madrid, Spain.; García-Cosío M; Department of Pathology, Hospital Universitario Ramón y Cajal, Madrid, Spain.; Piris-Villaespesa M; Department of Hematology, Hospital Universitario Ramón y Cajal, Madrid, Spain.; Llanos M; Department of Oncology, Hospital Universitario de Canarias, Tenerife, Spain.; García JF; Department of Pathology, Hospital MD Anderson Cancer Center, Madrid, Spain.; Sequero S; Department of Oncology, Hospital Universitario San Cecilio, Granada, Spain.; Mercadal S; Department of Hematology, ICO-Hospital Duran I Reynals, Barcelona, Spain.; García-Hernández S; Department of Pathology, Hospital Universitario de Canarias, Tenerife, Spain.; Navarro B; Department of Hematology, Hospital Universitario Puerta de Hierro, Majadahonda, Madrid, Spain.; Mollejo M; Department of Pathology, Complejo Hospitalario de Toledo, Spain.; Provencio M; Department of Medical Oncology, Lymphoma Research Group, Hospital Universitario Puerta de Hierro-Majadahonda, IDIPHISA, Madrid, Spain; Department of Medical Oncology, Hospital Universitario Puerta de Hierro-Majadahonda, Facultad de Medicina, Universidad Autónoma de Madrid, IDIPHISA, Madrid, Spain.; Sánchez-Beato M; Department of Medical Oncology, Lymphoma Research Group, Hospital Universitario Puerta de Hierro-Majadahonda, IDIPHISA, Madrid, Spain. Electronic address: msbeato@idiphim.org.
Publisher: Elsevier Inc Country of Publication: United States NLM ID: 8806605 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1530-0285 (Electronic) Linking ISSN: 08933952 NLM ISO Abbreviation: Mod Pathol Subsets: MEDLINE
Academic Journal
Figaredo G; Department of Haematology, Hospital Universitario de Toledo, Av. del Río Guadiana, 45007 Toledo, Spain.; Martín-Muñoz A; Altum Sequencing SL, Av. Gregorio Peces Barba, 1, 28919 Madrid, Spain.; Barrio S; Altum Sequencing SL, Av. Gregorio Peces Barba, 1, 28919 Madrid, Spain.; Computational Science Department, Carlos III University, Ronda de Toledo, 1, 28005 Madrid, Spain.; Parrilla L; Department of Haematology, Hospital Universitario de Toledo, Av. del Río Guadiana, 45007 Toledo, Spain.; Campos-Martín Y; Biobank Department, Hospital Universitario de Toledo, Av. del Río Guadiana, 45007 Toledo, Spain.; Poza M; Haematology Department, Hospital Universitario 12 de Octubre, Avda. de Córdoba, s/n, 28041 Madrid, Spain.; Rufián L; Altum Sequencing SL, Av. Gregorio Peces Barba, 1, 28919 Madrid, Spain.; Haematology Department, Hospital Universitario 12 de Octubre, Avda. de Córdoba, s/n, 28041 Madrid, Spain.; Algara P; Genetics Department, Hospital Universitario de Toledo, Av. del Río Guadiana, 45007 Toledo, Spain.; De La Torre M; Department of Haematology, Hospital Universitario de Toledo, Av. del Río Guadiana, 45007 Toledo, Spain.; Jiménez Ubieto A; Haematology Department, Hospital Universitario 12 de Octubre, Avda. de Córdoba, s/n, 28041 Madrid, Spain.; Martínez-López J; Haematology Department, Hospital Universitario 12 de Octubre, Avda. de Córdoba, s/n, 28041 Madrid, Spain.; Casado LF; Department of Haematology, Hospital Universitario de Toledo, Av. del Río Guadiana, 45007 Toledo, Spain.; Mollejo M; Anatomopathology Department, Hospital Universitario de Toledo, Av. del Río Guadiana, 45007 Toledo, Spain.
Publisher: MDPI Country of Publication: Switzerland NLM ID: 101526829 Publication Model: Electronic Cited Medium: Print ISSN: 2072-6694 (Print) Linking ISSN: 20726694 NLM ISO Abbreviation: Cancers (Basel) Subsets: PubMed not MEDLINE
Academic Journal
Rama TA; Serviço de Imunoalergologia, Centro Hospitalar Universitário São João, Porto, Portugal; Serviço de Imunologia Básica e Clínica, Departamento de Patologia, Faculdade de Medicina da Universidade do Porto, Porto, Portugal; EPIUnit, Institute of Public Health, University of Porto, Porto, Portugal; Laboratory for Integrative and Translational Research in Population Health, Porto, Portugal.; Torrado I; Instituto de Estudios de Mastocitosis de Castilla La Mancha, Reference Center for Mastocytosis, Hospital Virgen del Valle, Complejo Hospitalario Universitario de Toledo, Toledo, Spain.; Henriques AF; Instituto de Estudios de Mastocitosis de Castilla La Mancha, Reference Center for Mastocytosis, Hospital Virgen del Valle, Complejo Hospitalario Universitario de Toledo, Toledo, Spain; Spanish Network on Mastocytosis, Toledo and Salamanca, Spain.; Sánchez-Muñoz L; Instituto de Estudios de Mastocitosis de Castilla La Mancha, Reference Center for Mastocytosis, Hospital Virgen del Valle, Complejo Hospitalario Universitario de Toledo, Toledo, Spain; Spanish Network on Mastocytosis, Toledo and Salamanca, Spain; Centro de Investigación Biomédica en Red de Cáncer, Instituto de Salud Carlos III, Madrid, Spain.; Jara-Acevedo M; Spanish Network on Mastocytosis, Toledo and Salamanca, Spain; Centro de Investigación Biomédica en Red de Cáncer, Instituto de Salud Carlos III, Madrid, Spain; DNA Sequencing Service, Instituto de Investigación Biomédica de Salamanca, University of Salamanca, Salamanca, Spain.; Navarro-Navarro P; Spanish Network on Mastocytosis, Toledo and Salamanca, Spain; Centro de Investigación Biomédica en Red de Cáncer, Instituto de Salud Carlos III, Madrid, Spain; DNA Sequencing Service, Instituto de Investigación Biomédica de Salamanca, University of Salamanca, Salamanca, Spain.; Caldas C; Spanish Network on Mastocytosis, Toledo and Salamanca, Spain; Centro de Investigación Biomédica en Red de Cáncer, Instituto de Salud Carlos III, Madrid, Spain; DNA Sequencing Service, Instituto de Investigación Biomédica de Salamanca, University of Salamanca, Salamanca, Spain.; Mayado A; Spanish Network on Mastocytosis, Toledo and Salamanca, Spain; Centro de Investigación Biomédica en Red de Cáncer, Instituto de Salud Carlos III, Madrid, Spain; Cancer Research Center, Department of Medicine, Cytometry Service, Instituto de Investigación Biomédica de Salamanca, University of Salamanca, Salamanca, Spain.; Muñoz-González J; Spanish Network on Mastocytosis, Toledo and Salamanca, Spain; Centro de Investigación Biomédica en Red de Cáncer, Instituto de Salud Carlos III, Madrid, Spain; Cancer Research Center, Department of Medicine, Cytometry Service, Instituto de Investigación Biomédica de Salamanca, University of Salamanca, Salamanca, Spain.; García-Montero A; Spanish Network on Mastocytosis, Toledo and Salamanca, Spain; Centro de Investigación Biomédica en Red de Cáncer, Instituto de Salud Carlos III, Madrid, Spain; Cancer Research Center, Department of Medicine, Cytometry Service, Instituto de Investigación Biomédica de Salamanca, University of Salamanca, Salamanca, Spain.; Mollejo M; Pathology Department, Hospital Virgen de la Salud, Complejo Hospitalario Universitario de Toledo, Toledo, Spain.; Redondo E; Servicio de Alergologia, Hospital Clínico San Carlos, Madrid, Spain.; Garbán A; Servicio de Alergologia, Hospital Clínico San Carlos, Madrid, Spain.; Moreira A; Serviço de Imunoalergologia, Centro Hospitalar Universitário São João, Porto, Portugal; Serviço de Imunologia Básica e Clínica, Departamento de Patologia, Faculdade de Medicina da Universidade do Porto, Porto, Portugal; EPIUnit, Institute of Public Health, University of Porto, Porto, Portugal; Laboratory for Integrative and Translational Research in Population Health, Porto, Portugal.; Órfão A; Spanish Network on Mastocytosis, Toledo and Salamanca, Spain; Centro de Investigación Biomédica en Red de Cáncer, Instituto de Salud Carlos III, Madrid, Spain; Cancer Research Center, Department of Medicine, Cytometry Service, Instituto de Investigación Biomédica de Salamanca, University of Salamanca, Salamanca, Spain.; Álvarez-Twose I; Instituto de Estudios de Mastocitosis de Castilla La Mancha, Reference Center for Mastocytosis, Hospital Virgen del Valle, Complejo Hospitalario Universitario de Toledo, Toledo, Spain; Spanish Network on Mastocytosis, Toledo and Salamanca, Spain; Centro de Investigación Biomédica en Red de Cáncer, Instituto de Salud Carlos III, Madrid, Spain. Electronic address: ivana@sescam.jccm.es.
Publisher: Elsevier Inc Country of Publication: United States NLM ID: 101597220 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2213-2201 (Electronic) NLM ISO Abbreviation: J Allergy Clin Immunol Pract Subsets: MEDLINE
Academic Journal
Jiménez-Ubieto A; Department of Hematology, Hospital Universitario 12 de Octubre, Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), CNIO, CIBERONC, Madrid, Spain. anitiju@hotmail.com.; Poza M; Department of Hematology, Hospital Universitario 12 de Octubre, Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), CNIO, CIBERONC, Madrid, Spain.; Martin-Muñoz A; Altum sequencing Co., Madrid, Spain.; Ruiz-Heredia Y; Department of Hematology, Hospital Universitario 12 de Octubre, Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), CNIO, CIBERONC, Madrid, Spain.; Altum sequencing Co., Madrid, Spain.; Dorado S; Altum sequencing Co., Madrid, Spain.; Computational Science Department, Carlos III University, Madrid, Spain.; Figaredo G; Hospital General Universitario de Toledo, Toledo, Spain.; Rosa-Rosa JM; Department of Hematology, Hospital Universitario 12 de Octubre, Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), CNIO, CIBERONC, Madrid, Spain.; Rodriguez A; Department of Hematology, Hospital Universitario 12 de Octubre, Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), CNIO, CIBERONC, Madrid, Spain.; Barcena C; Hospital Universitario 12 de Octubre, Departamento de Anatomía Patológica, Madrid, Spain.; Navamuel LP; Hospital General Universitario de Toledo, Toledo, Spain.; Carrillo J; Altum sequencing Co., Madrid, Spain.; Sanchez R; Department of Hematology, Hospital Universitario 12 de Octubre, Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), CNIO, CIBERONC, Madrid, Spain.; Altum sequencing Co., Madrid, Spain.; Rufian L; Department of Hematology, Hospital Universitario 12 de Octubre, Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), CNIO, CIBERONC, Madrid, Spain.; Altum sequencing Co., Madrid, Spain.; Juárez A; Department of Hematology, Hospital Universitario 12 de Octubre, Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), CNIO, CIBERONC, Madrid, Spain.; Altum sequencing Co., Madrid, Spain.; Rodriguez M; Department of Hematology, Hospital Universitario 12 de Octubre, Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), CNIO, CIBERONC, Madrid, Spain.; Altum sequencing Co., Madrid, Spain.; Wang C; Hosea Precision Medical Technology Co., Ltd., Weihai, Shangdong, China.; de Toledo P; Computational Science Department, Carlos III University, Madrid, Spain.; Grande C; Clínica Universitaria de Navarra, Madrid, Spain.; Mollejo M; Hospital General Universitario de Toledo, Toledo, Spain.; Casado LF; Hospital General Universitario de Toledo, Toledo, Spain.; Calbacho M; Department of Hematology, Hospital Universitario 12 de Octubre, Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), CNIO, CIBERONC, Madrid, Spain.; Baumann T; Department of Hematology, Hospital Universitario 12 de Octubre, Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), CNIO, CIBERONC, Madrid, Spain.; Rapado I; Department of Hematology, Hospital Universitario 12 de Octubre, Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), CNIO, CIBERONC, Madrid, Spain.; Gallardo M; Department of Hematology, Hospital Universitario 12 de Octubre, Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), CNIO, CIBERONC, Madrid, Spain.; H12O-CNIO Haematological Malignancies Clinical Research Unit, CNIO, Madrid, Spain.; Sarandeses P; Hospital Universitario 12 de Octubre, Departamento de Medicina Nuclear, Madrid, Spain.; Ayala R; Department of Hematology, Hospital Universitario 12 de Octubre, Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), CNIO, CIBERONC, Madrid, Spain.; Martínez-López J; Department of Hematology, Hospital Universitario 12 de Octubre, Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), CNIO, CIBERONC, Madrid, Spain.; Barrio S; Department of Hematology, Hospital Universitario 12 de Octubre, Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), CNIO, CIBERONC, Madrid, Spain. santibarrio0.3@gmail.com.; Altum sequencing Co., Madrid, Spain. santibarrio0.3@gmail.com.
Publisher: Nature Publishing Group, Specialist Journals Country of Publication: England NLM ID: 8704895 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5551 (Electronic) Linking ISSN: 08876924 NLM ISO Abbreviation: Leukemia Subsets: MEDLINE
Academic Journal
Bonfiglio F; Experimental Hematology, Institute of Oncology Research, Bellinzona, Switzerland.; Bruscaggin A; Experimental Hematology, Institute of Oncology Research, Bellinzona, Switzerland.; Guidetti F; Experimental Hematology, Institute of Oncology Research, Bellinzona, Switzerland.; Terzi di Bergamo L; Experimental Hematology, Institute of Oncology Research, Bellinzona, Switzerland.; Faderl M; Experimental Hematology, Institute of Oncology Research, Bellinzona, Switzerland.; Spina V; Experimental Hematology, Institute of Oncology Research, Bellinzona, Switzerland.; Condoluci A; Experimental Hematology, Institute of Oncology Research, Bellinzona, Switzerland.; Division of Hematology, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland.; Bonomini L; International Extranodal Lymphoma Study Group, Bellinzona, Switzerland.; Forestieri G; Experimental Hematology, Institute of Oncology Research, Bellinzona, Switzerland.; Koch R; Experimental Hematology, Institute of Oncology Research, Bellinzona, Switzerland.; Piffaretti D; Experimental Hematology, Institute of Oncology Research, Bellinzona, Switzerland.; Pini K; Experimental Hematology, Institute of Oncology Research, Bellinzona, Switzerland.; Pirosa MC; Division of Hematology, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland.; Cittone MG; Experimental Hematology, Institute of Oncology Research, Bellinzona, Switzerland.; Division of Hematology, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland.; Arribas A; Lymphoma Genomics, Institute of Oncology Research, Bellinzona, Switzerland.; Lucioni M; Unit of Anatomic Pathology, Department of Molecular Medicine, Fondazione IRCCS Policlinico San Matteo and Università degli Studi di Pavia, Pavia, Italy.; Ghilardi G; Division of Hematology, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland.; Wu W; Experimental Hematology, Institute of Oncology Research, Bellinzona, Switzerland.; Arcaini L; Division of Hematology, Fondazione IRCCS Policlinico San Matteo and Department of Molecular Medicine, University of Pavia, Pavia, Italy.; Baptista MJ; Lymphoid Neoplasms Group, Josep Carreras Leukaemia Research Institute, Badalona, Spain.; Bastidas G; Division of Hematology, Hospital Clínic i Provincial de Barcelona, Barcelona, Spain.; Bea S; Institut d'Investigacions Biomèdiques August Pi Sunyer (IDIBAPS).; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC) 28029, Madrid, Spain.; Pathology Department, Hospital Clínic, Barcelona University, Barcelona, Spain.; Boldorini R; Division of Pathology, University of Eastern Piedmont, Novara, Italy.; Broccoli A; IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia Seràgnoli, Bologna, Italy.; Buehler MM; Department of Medical Oncology and Hematology, University Hospital Zurich, Zurich, Switzerland.; Canzonieri V; Pathology Unit, CRO Aviano National Cancer Institute, Aviano, Italy.; Department of Medical, Surgical and Health Sciences, University of Trieste, Trieste, Italy.; Cascione L; Lymphoma Genomics, Institute of Oncology Research, Bellinzona, Switzerland.; Ceriani L; Clinic of Nuclear Medicine and PET-CT Centre, Imaging Institute of Southern Switzerland, Bellinzona, Switzerland.; Cogliatti S; Institute of Pathology, Kantonsspital St Gallen, St Gallen, Switzerland.; Corradini P; Division of Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.; Derenzini E; Onco-hematology Division, European Institute of Oncology (IEO) IRCCS, Milan, Italy.; Devizzi L; Division of Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.; Dietrich S; Division of Hematology, University Hospital Heidelberg, Heidelberg, Germany.; Elia AR; Cancer Immunotherapy, Institute of Oncology Research, Bellinzona, Switzerland.; Facchetti F; Department of Molecular and Translational Medicine, Pathology Unit, Spedali Civili, Brescia, Italy.; Gaidano G; Division of Hematology, Department of Translational Medicine, University of Eastern Piedmont, Novara, Italy.; Garcia JF; Division of Pathology, MD Anderson Cancer Center, Madrid, Spain.; Gerber B; Division of Hematology, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland.; Department of Hematology and Oncology, University of Zurich, Zurich, Switzerland.; Ghia P; Strategic Research Program on Chronic Lymphocytic Leukemia (CLL), IRCCS Ospedale San Raffaele and Università Vita-Salute San Raffaele, Milan, Italy.; Gomes da Silva M; Division of Hematology, Instituto Português de Oncologia de Lisboa, Lisbon, Portugal.; Gritti G; Division of Hematology, Azienda Ospedaliera Papa Giovanni XXIII, Bergamo, Italy.; Guidetti A; Division of Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.; Hitz F; Division of Hematology, Kantonsspital St Gallen, St Gallen, Switzerland.; Inghirami G; Department of Pathology and Laboratory Medicine, Weill Cornell Medical College, New York, NY.; Ladetto M; Division of Hematology, Azienda Ospedaliera SS Antonio e Biagio, Alessandria, Italy.; Dipartimento di Medicina Traslazionale, University of Eastern Piedmont, Alessandria, Italy.; Lopez-Guillermo A; Division of Lymphoid Neoplasms, Hospital Clínic i Provincial de Barcelona, Barcelona, Spain.; Lucchini E; Division of Hematology, Azienda Sanitaria Universitaria Giuliano Isontina, Trieste, Italy.; Maiorana A; Division of Pathology, Universitá degli Studi di Modena e Reggio Emilia, Modena, Italy.; Marasca R; Hematology Unit, Department of Medical and Surgical Sciences, University of Modena and Reggio Emilia, Modena, Italy.; Matutes E; Haematopathology Unit, Hospital Clínic i Provincial de Barcelona, Barcelona, Spain.; Meignin V; Division of Pathology, Saint Louis Hospital, Paris, France.; Merli M; Division of Hematology, University of Insubria and ASST Sette Laghi, Ospedale di Circolo of Varese, Varese, Italy.; Moccia A; Clinic of Medical Oncology, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland.; Mollejo M; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC) 28029, Madrid, Spain.; Division of Pathology, Hospital Virgen de la Salud, Toledo, Spain.; Montalban C; Division of Hematology, MD Anderson Cancer Center, Madrid, Spain.; Novak U; Department of Medical Oncology and University Cancer Center, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.; Oscier DG; Division of Hematology, University Hospitals Dorset, Bournemouth, United Kingdom.; Passamonti F; Department of Medicine and Surgery, University of Insubria and ASST Sette Laghi, Ospedale di Circolo of Varese, Varese, Italy.; Piazza F; Division of Hematology, Ospedale Universitario di Padova, Padova, Italy.; Pizzolitto S; Division of Pathology, General Hospital S Maria della Misericordia, Udine, Italy.; Rambaldi A; Division of Hematology, Azienda Ospedaliera Papa Giovanni XXIII, Bergamo, Italy.; Sabattini E; Haematopathology Unit, Department of Experimental Diagnostic and Specialty Medicine (DIMES), University of Bologna, Bologna, Italy.; Salles G; Faculté de Médecine et de Maïeutique Lyon Sud, Université de Lyon, Lyon, France.; Santambrogio E; Candiolo Cancer Institute (FPO-IRCCS), Candiolo, Turin, Italy.; Scarfò L; Strategic Research Program on Chronic Lymphocytic Leukemia (CLL), IRCCS Ospedale San Raffaele and Università Vita-Salute San Raffaele, Milan, Italy.; Stathis A; Clinic of Medical Oncology, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland.; Stüssi G; Division of Hematology, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland.; Faculty of Biomedical Sciences, Università della Svizzera Italiana (USI), Lugano, Switzerland.; Geyer JT; Division of Anatomic Pathology and Clinical Pathology, Weill Cornell Medical College, New York, NY.; Tapia G; Division of Pathology, Hospital Germans Trias I Pujol, Universitat Autònoma de Barcelona, Barcelona, Spain.; Tarella C; Onco-hematology Division, European Institute of Oncology (IEO) IRCCS, Milan, Italy.; Thieblemont C; Assistance Publique-Hôpitaux de Paris, Hopital Saint-Louis, Hemato-Oncology Unit; Université de Paris, Paris, France.; Tousseyn T; Department of Haematology, University Hospitals Leuven, Leuven, Belgium.; Tucci A; Division of Hematology, Spedali Civili, Brescia, Italy.; Vanini G; Department of Medical Oncology and University Cancer Center, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.; Visco C; Department of Medicine, Section of Hematology, University of Verona, Italy.; Vitolo U; Candiolo Cancer Institute (FPO-IRCCS), Candiolo, Turin, Italy.; Walewska R; Division of Hematology, University Hospitals Dorset, Bournemouth, United Kingdom.; Zaja F; Division of Hematology, Azienda Sanitaria Universitaria Giuliano Isontina, Trieste, Italy.; Zenz T; Department of Medical Oncology and Hematology, University Hospital Zurich, Zurich, Switzerland.; Zinzani PL; IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia Seràgnoli, Bologna, Italy.; Dipartimento di Medicina Specialistica, Diagnostica e Sperimentale, Università di Bologna, Bologna, Italy.; Khiabanian H; Center for Systems and Computational Biology, Rutgers University, New Brunswick, NJ.; Calcinotto A; Cancer Immunotherapy, Institute of Oncology Research, Bellinzona, Switzerland.; Bertoni F; Lymphoma Genomics, Institute of Oncology Research, Bellinzona, Switzerland.; Clinic of Medical Oncology, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland.; Faculty of Biomedical Sciences, Università della Svizzera Italiana (USI), Lugano, Switzerland.; Bhagat G; Department of Pathology and Cell Biology, Columbia University, New York, NY.; Campo E; Institut d'Investigacions Biomèdiques August Pi Sunyer (IDIBAPS).; Pathology Department, Hospital Clínic, Barcelona University, Barcelona, Spain.; De Leval L; Division of Pathology, Institut Universitaire de Pathologie, Lausanne, Switzerland.; Dirnhofer S; Institute of Pathology and Medical Genetics, University Hospital Basel, Basel, Switzerland.; Pileri SA; Haematopathology Division, European Institute of Oncology IRCCS, Milan, Italy.; Piris MA; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC) 28029, Madrid, Spain.; Pathology Service, Fundación Jiménez Díaz, Madrid, Spain.; Traverse-Glehen A; Division of Pathology, Centre Hospitalier Lyon Sud, Lyon, France.; Tzankov A; Institute of Pathology and Medical Genetics, University Hospital Basel, Basel, Switzerland.; Paulli M; Unit of Anatomic Pathology, Department of Molecular Medicine, Fondazione IRCCS Policlinico San Matteo and Università degli Studi di Pavia, Pavia, Italy.; Ponzoni M; Ateneo Vita-Salute San Raffaele University and Pathology Unit San Raffaele Scientific Institute, Milan, Italy.; Mazzucchelli L; Division of Pathology, Cantonal Institute of Pathology, Locarno, Switzerland.; Cavalli F; Institute of Oncology Research, Bellinzona, Switzerland; and.; Zucca E; International Extranodal Lymphoma Study Group, Bellinzona, Switzerland.; Clinic of Medical Oncology, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland.; Faculty of Biomedical Sciences, Università della Svizzera Italiana (USI), Lugano, Switzerland.; Department of Medical Oncology, Bern University Hospital and University of Bern, Bern, Switzerland.; Rossi D; Experimental Hematology, Institute of Oncology Research, Bellinzona, Switzerland.; Division of Hematology, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland.; Faculty of Biomedical Sciences, Università della Svizzera Italiana (USI), Lugano, Switzerland.
Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE
Academic Journal
Rodríguez M; Pathology Department, Instituto de Investigación Sanitaria Fundación Jiménez Díaz, Madrid, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), ISCIII, Madrid, Spain.; Alonso-Alonso R; Pathology Department, Instituto de Investigación Sanitaria Fundación Jiménez Díaz, Madrid, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), ISCIII, Madrid, Spain.; Tomás-Roca L; Pathology Department, Instituto de Investigación Sanitaria Fundación Jiménez Díaz, Madrid, Spain.; Rodríguez-Pinilla SM; Pathology Department, Instituto de Investigación Sanitaria Fundación Jiménez Díaz, Madrid, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), ISCIII, Madrid, Spain.; Manso-Alonso R; Pathology Department, Instituto de Investigación Sanitaria Fundación Jiménez Díaz, Madrid, Spain.; Cereceda L; Pathology Department, Instituto de Investigación Sanitaria Fundación Jiménez Díaz, Madrid, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), ISCIII, Madrid, Spain.; Borregón J; Pathology Department, Instituto de Investigación Sanitaria Fundación Jiménez Díaz, Madrid, Spain.; Villaescusa T; Lymphoma Unit, Department of Hematology, Fundación Jiménez Díaz University Hospital, Health Research Institute IIS-FJD, Madrid, Spain.; Córdoba R; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), ISCIII, Madrid, Spain.; Lymphoma Unit, Department of Hematology, Fundación Jiménez Díaz University Hospital, Health Research Institute IIS-FJD, Madrid, Spain.; Sánchez-Beato M; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), ISCIII, Madrid, Spain.; Lymphoma Research Group, Medical Oncology Department, Instituto de Investigación Sanitaria Puerta de Hierro-Segovia de Arana, Madrid, Spain.; Fernández-Miranda I; Lymphoma Research Group, Medical Oncology Department, Instituto de Investigación Sanitaria Puerta de Hierro-Segovia de Arana, Madrid, Spain.; Betancor I; Pathology Department, Instituto de Investigación Sanitaria Fundación Jiménez Díaz, Madrid, Spain.; Bárcena C; Pathology Department, Hospital Universitario 12 de Octubre, Madrid, Spain.; García JF; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), ISCIII, Madrid, Spain.; Pathology Department, Hospital MD Anderson Cancer Center, Madrid, Spain.; Mollejo M; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), ISCIII, Madrid, Spain.; Pathology Department, Hospital Virgen de la Salud, Toledo, Spain.; García-Cosio M; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), ISCIII, Madrid, Spain.; Pathology Department, Hospital Universitario Ramón y Cajal, Madrid, Spain.; Martin-Acosta P; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), ISCIII, Madrid, Spain.; Pathology Department, Hospital Universitario Puerta de Hierro-Segovia de Arana, Madrid, Spain.; Climent F; Pathology Department, Hospital Universitari de Bellvitge, IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain.; Caballero D; Haematology Department, Hospitalario Universitario de Salamanca (HUS/IBSAL), Salamanca, Spain.; de la Fuente L; Bioinformatics Unit, Instituto de Investigación Sanitaria-Fundación Jiménez Díaz University Hospital, Universidad Autónoma de Madrid (IIS-FJD, UAM), Madrid, Spain.; Department of Genetics, Instituto de Investigación Sanitaria-Fundación Jiménez Díaz University Hospital, Universidad Autónoma de Madrid (IIS-FJD, UAM), Madrid, Spain.; Mínguez P; Bioinformatics Unit, Instituto de Investigación Sanitaria-Fundación Jiménez Díaz University Hospital, Universidad Autónoma de Madrid (IIS-FJD, UAM), Madrid, Spain.; Department of Genetics, Instituto de Investigación Sanitaria-Fundación Jiménez Díaz University Hospital, Universidad Autónoma de Madrid (IIS-FJD, UAM), Madrid, Spain.; Center for Biomedical Network Research on Rare Diseases (CIBERER), ISCIII, Madrid, Spain.; Kessler L; Kura Oncology Inc., San Diego, CA; and.; Scholz C; Kura Oncology Inc., San Diego, CA; and.; Gualberto A; Kura Oncology Inc., San Diego, CA; and.; Mondéjar R; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), ISCIII, Madrid, Spain.; UGC Laboratorios, Hospital Universitario de Puerto Real, Cádiz, Spain.; Piris MA; Pathology Department, Instituto de Investigación Sanitaria Fundación Jiménez Díaz, Madrid, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), ISCIII, Madrid, Spain.
Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE
Academic Journal
López V; Cancer Epigenetics and Nanomedicine Laboratory, Department of Organisms and Systems Biology, Nanomaterials and Nanotechnology Research Center (CINN-CSIC), Health Research Institute of Asturias (ISPA), Institute of Oncology of Asturias (IUOPA), Rare Diseases CIBER (CIBERER) of the Carlos III Health Institute (ISCIII), University of Oviedo, Oviedo, Spain.; Tejedor JR; Cancer Epigenetics and Nanomedicine Laboratory, Department of Organisms and Systems Biology, Nanomaterials and Nanotechnology Research Center (CINN-CSIC), Health Research Institute of Asturias (ISPA), Institute of Oncology of Asturias (IUOPA), Rare Diseases CIBER (CIBERER) of the Carlos III Health Institute (ISCIII), University of Oviedo, Oviedo, Spain.; Carella A; Cancer Epigenetics and Nanomedicine Laboratory, Department of Organisms and Systems Biology, Nanomaterials and Nanotechnology Research Center (CINN-CSIC), Health Research Institute of Asturias (ISPA), Institute of Oncology of Asturias (IUOPA), Rare Diseases CIBER (CIBERER) of the Carlos III Health Institute (ISCIII), University of Oviedo, Oviedo, Spain.; García MG; Cancer Epigenetics and Nanomedicine Laboratory, Department of Organisms and Systems Biology, Nanomaterials and Nanotechnology Research Center (CINN-CSIC), Health Research Institute of Asturias (ISPA), Institute of Oncology of Asturias (IUOPA), Rare Diseases CIBER (CIBERER) of the Carlos III Health Institute (ISCIII), University of Oviedo, Oviedo, Spain.; Santamarina-Ojeda P; Cancer Epigenetics and Nanomedicine Laboratory, Department of Organisms and Systems Biology, Nanomaterials and Nanotechnology Research Center (CINN-CSIC), Health Research Institute of Asturias (ISPA), Institute of Oncology of Asturias (IUOPA), Rare Diseases CIBER (CIBERER) of the Carlos III Health Institute (ISCIII), University of Oviedo, Oviedo, Spain.; Pérez RF; Cancer Epigenetics and Nanomedicine Laboratory, Department of Organisms and Systems Biology, Nanomaterials and Nanotechnology Research Center (CINN-CSIC), Health Research Institute of Asturias (ISPA), Institute of Oncology of Asturias (IUOPA), Rare Diseases CIBER (CIBERER) of the Carlos III Health Institute (ISCIII), University of Oviedo, Oviedo, Spain.; Mangas C; Cancer Epigenetics and Nanomedicine Laboratory, Department of Organisms and Systems Biology, Nanomaterials and Nanotechnology Research Center (CINN-CSIC), Health Research Institute of Asturias (ISPA), Institute of Oncology of Asturias (IUOPA), Rare Diseases CIBER (CIBERER) of the Carlos III Health Institute (ISCIII), University of Oviedo, Oviedo, Spain.; Urdinguio RG; Cancer Epigenetics and Nanomedicine Laboratory, Department of Organisms and Systems Biology, Nanomaterials and Nanotechnology Research Center (CINN-CSIC), Health Research Institute of Asturias (ISPA), Institute of Oncology of Asturias (IUOPA), Rare Diseases CIBER (CIBERER) of the Carlos III Health Institute (ISCIII), University of Oviedo, Oviedo, Spain.; Aranburu A; Cancer Epigenetics and Nanomedicine Laboratory, Department of Organisms and Systems Biology, Nanomaterials and Nanotechnology Research Center (CINN-CSIC), Health Research Institute of Asturias (ISPA), Institute of Oncology of Asturias (IUOPA), Rare Diseases CIBER (CIBERER) of the Carlos III Health Institute (ISCIII), University of Oviedo, Oviedo, Spain.; de la Nava D; Cancer Epigenetics and Nanomedicine Laboratory, Department of Organisms and Systems Biology, Nanomaterials and Nanotechnology Research Center (CINN-CSIC), Health Research Institute of Asturias (ISPA), Institute of Oncology of Asturias (IUOPA), Rare Diseases CIBER (CIBERER) of the Carlos III Health Institute (ISCIII), University of Oviedo, Oviedo, Spain.; Corte-Torres MD; Biobanco del Principado de Asturias, Hospital Universitario Central de Asturias (HUCA), Oviedo, Spain.; Astudillo A; Departamento de Anatomía Patológica, Hospital Universitario Central de Asturias (HUCA), Oviedo, Spain.; Mollejo M; Departamento de Patología, Hospital Virgen de la Salud (CHT), Toledo, Spain.; Meléndez B; Departamento de Patología, Hospital Virgen de la Salud (CHT), Toledo, Spain.; Fernández AF; Cancer Epigenetics and Nanomedicine Laboratory, Department of Organisms and Systems Biology, Nanomaterials and Nanotechnology Research Center (CINN-CSIC), Health Research Institute of Asturias (ISPA), Institute of Oncology of Asturias (IUOPA), Rare Diseases CIBER (CIBERER) of the Carlos III Health Institute (ISCIII), University of Oviedo, Oviedo, Spain.; Fraga MF; Cancer Epigenetics and Nanomedicine Laboratory, Department of Organisms and Systems Biology, Nanomaterials and Nanotechnology Research Center (CINN-CSIC), Health Research Institute of Asturias (ISPA), Institute of Oncology of Asturias (IUOPA), Rare Diseases CIBER (CIBERER) of the Carlos III Health Institute (ISCIII), University of Oviedo, Oviedo, Spain.
Publisher: Frontiers Media S.A Country of Publication: Switzerland NLM ID: 101630250 Publication Model: eCollection Cited Medium: Print ISSN: 2296-634X (Print) Linking ISSN: 2296634X NLM ISO Abbreviation: Front Cell Dev Biol Subsets: PubMed not MEDLINE
Academic Journal
Vergara-de-la-Campa L; Dermatology Department, Complejo Hospitalario de Toledo, Toledo, Spain.; Torrado I; Spanish Reference Center of Mastocytosis, Instituto de Estudios de Mastocitosis de Castilla-La Mancha (CLMast), Hospital Virgen del Valle, Complejo Hospitalario de Toledo, Toledo, Spain.; Recuero-Pradillo M; Pathology Department, Complejo Hospitalario de Toledo, Toledo, Spain.; Torrelo A; Dermatology Department, Hospital Infantil Universitario Niño Jesús, Madrid, Spain.; Gironella M; Hematology Department, Hospital Universitario Vall d'Hebron, Barcelona, Spain.; Pardal E; Hematology Department, Hospital Virgen del Puerto, Plasencia, Spain.; Godoy AC; Hematology Department, Hospital Universitario Miguel Servet, Zaragoza, Spain.; Matito A; Spanish Reference Center of Mastocytosis, Instituto de Estudios de Mastocitosis de Castilla-La Mancha (CLMast), Hospital Virgen del Valle, Complejo Hospitalario de Toledo, Toledo, Spain.; Spanish Network on Mastocytosis (REMA), Toledo, Spain.; Pérez-Hortet C; Dermatology Department, Complejo Hospitalario de Toledo, Toledo, Spain.; Mollejo M; Pathology Department, Complejo Hospitalario de Toledo, Toledo, Spain.; Álvarez-Twöse I; Spanish Reference Center of Mastocytosis, Instituto de Estudios de Mastocitosis de Castilla-La Mancha (CLMast), Hospital Virgen del Valle, Complejo Hospitalario de Toledo, Toledo, Spain.; Spanish Network on Mastocytosis (REMA), Toledo, Spain.
Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 7600545 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1346-8138 (Electronic) Linking ISSN: 03852407 NLM ISO Abbreviation: J Dermatol Subsets: MEDLINE
Academic Journal
Pedrosa L; Lymphoma Research Group, Medical Oncology Department, Instituto de Investigación Sanitaria Puerta de Hierro-Segovia de Arana, Majadahonda, Madrid, Spain.; PhD Program in Molecular Biosciences, Doctoral School, Universidad Autónoma de Madrid, Madrid, Spain.; Fernández-Miranda I; Lymphoma Research Group, Medical Oncology Department, Instituto de Investigación Sanitaria Puerta de Hierro-Segovia de Arana, Majadahonda, Madrid, Spain.; PhD Program in Molecular Biosciences, Doctoral School, Universidad Autónoma de Madrid, Madrid, Spain.; Pérez-Callejo D; Medical Oncology Department, Hospital Universitario Puerta de Hierro-Majadahonda, Madrid, Spain.; PhD Program in Medicine and Surgery, Doctoral School, Universidad Autónoma de Madrid, Madrid, Spain.; Quero C; Medical Oncology Department, Hospital Universitario Virgen de La Victoria, Malaga, Spain.; Rodríguez M; Pathology Department, Hospital Fundación Jiménez Díaz, Madrid, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.; Martín-Acosta P; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.; Molecular Pathology Laboratory, Instituto de Investigación Sanitaria Puerta de Hierro-Segovia de Arana, Madrid, Spain.; Gómez S; Lymphoma Research Group, Medical Oncology Department, Instituto de Investigación Sanitaria Puerta de Hierro-Segovia de Arana, Majadahonda, Madrid, Spain.; González-Rincón J; Lymphoma Research Group, Medical Oncology Department, Instituto de Investigación Sanitaria Puerta de Hierro-Segovia de Arana, Majadahonda, Madrid, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.; Santos A; Molecular Pathology Laboratory, Instituto de Investigación Sanitaria Puerta de Hierro-Segovia de Arana, Madrid, Spain.; Tarin C; Bioinformatics Unit, Instituto de Investigación Sanitaria Puerta de Hierro-Segovia de Arana, Madrid, Spain.; Basic Medical Sciences, Faculty of Medicine, Universidad CEU San Pablo, Madrid, Spain.; García JF; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.; Pathology Department, MD Anderson Cancer Center, Madrid, Spain.; García-Arroyo FR; Medical Oncology Department, Complejo Hospitalario de Pontevedra, Pontevedra, Spain.; Rueda A; Medical Oncology Department, Hospitales Universitarios Regional y Virgen de La Victoria, IBIMA, Malaga, Spain.; Camacho FI; Pathology Department, Hospital Universitario de Getafe, Madrid, Spain.; García-Cosío M; Pathology Department, Hospital Universitario Ramón y Cajal, Madrid, Spain.; Heredero A; Lymphoma Research Group, Medical Oncology Department, Instituto de Investigación Sanitaria Puerta de Hierro-Segovia de Arana, Majadahonda, Madrid, Spain.; Llanos M; Medical Oncology Department, Hospital Universitario de Canarias, Tenerife, Spain.; Mollejo M; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.; Pathology Department, Complejo Hospitalario de Toledo, Toledo, Spain.; Piris-Villaespesa M; Haematology Department, Hospital Universitario Ramón y Cajal, Madrid, Spain.; Gómez-Codina J; Medical Oncology Department, Hospital Universitari i Politècnic La Fe, Valencia, Spain.; Yanguas-Casás N; Lymphoma Research Group, Medical Oncology Department, Instituto de Investigación Sanitaria Puerta de Hierro-Segovia de Arana, Majadahonda, Madrid, Spain.; Sánchez A; Medical Oncology Department, Hospital Universitario Puerta de Hierro-Majadahonda, Madrid, Spain.; Piris MA; Pathology Department, Hospital Fundación Jiménez Díaz, Madrid, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.; Provencio M; Medical Oncology Department, Hospital Universitario Puerta de Hierro-Majadahonda, Madrid, Spain.; Sánchez-Beato M; Lymphoma Research Group, Medical Oncology Department, Instituto de Investigación Sanitaria Puerta de Hierro-Segovia de Arana, Majadahonda, Madrid, Spain. msbeato@idiphim.org.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain. msbeato@idiphim.org.
Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE
Academic Journal
Publisher: Dustri-Verlag Country of Publication: Germany NLM ID: 8214420 Publication Model: Print Cited Medium: Internet ISSN: 0722-5091 (Print) Linking ISSN: 07225091 NLM ISO Abbreviation: Clin Neuropathol Subsets: MEDLINE
검색 결과 제한하기
제한된 항목
[AR] Mollejo M
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어